POC(Point-Of-Care) 분자진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global point-of-care molecular diagnostics market size is expected to reach USD 16.69 Billion in 2034 from USD 9.25 Billion in 2025, growing at a CAGR of 6.78 during 2026-2034.This market is experiencing robust growth as healthcare providers increasingly require rapid and accurate diagnostic solutions at the point of patient care. Point-of-care molecular diagnostics enable quick detection of infectious diseases, genetic conditions, and other medical disorders without relying on centralized laboratory testing. Rising demand for early disease diagnosis, expanding healthcare accessibility, and increasing awareness of preventive healthcare are driving widespread adoption of these advanced diagnostic technologies.

Advancements in molecular biology, portable diagnostic devices, and nucleic acid testing technologies are improving testing speed, sensitivity, and accuracy. Healthcare facilities are adopting compact diagnostic platforms that provide timely clinical results, supporting faster treatment decisions and improved patient outcomes. Growing investments in infectious disease surveillance, personalized medicine, and decentralized healthcare services are creating favorable market conditions. Integration with digital healthcare systems is further enhancing clinical efficiency.

The future outlook remains highly encouraging as healthcare systems continue prioritizing rapid diagnostics and personalized patient care. Artificial intelligence, automated sample processing, and connected diagnostic platforms will improve operational efficiency and expand testing capabilities. Rising demand from emergency care, home healthcare, and remote medical services will generate significant growth opportunities. Continuous technological innovation will strengthen the role of point-of-care molecular diagnostics in modern healthcare.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

• PCR-based
• Genetic Sequencing-based
• Hybridization-based
• Microarray-based

By Application

• Infectious Diseases (HIV POC, Clostridioides difficile POC, HBV POC, Pneumonia or Streptococcus-Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and Drug-Resistant TB POC, HSV POC, Other Infectious Diseases)
• Oncology
• Hematology
• Prenatal Testing
• Endocrinology
• Other Applications

By Test Location

• OTC
• POC

By End Use

• Decentralized Labs
• Hospitals
• Home Care
• Assisted Living Healthcare Facilities
• Others

COMPANIES PROFILED

• F. Hoffmann-La Roche, Abbott, QIAGEN, Danaher Corporation, bioMerieux, OraSure Technologies, binx health, QuidelOrtho, Cepheid, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, Hologic, SEKISUI Diagnostics, Bosch Healthcare Solutions, Trivitron Healthcare, Meridian Bioscience, GenMark Diagnostics, Mesa Biotech, Molbio Diagnostics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. PCR-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Genetic Sequencing-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hybridization-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Microarray-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Infectious Diseases (HIV POC, Clostridioides difficile POC, HBV POC, Pneumonia or Streptococcus-Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and Drug-Resistant TB POC, HSV POC, Other Infectious Diseases) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Prenatal Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: BY TEST LOCATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Location
• 6.2. OTC Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. POC Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Decentralized Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Assisted Living Healthcare Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Technology
  • 8.2.2 By Application
  • 8.2.3 By Test Location
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Technology
  • 8.3.2 By Application
  • 8.3.3 By Test Location
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Technology
  • 8.4.2 By Application
  • 8.4.3 By Test Location
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Technology
  • 8.5.2 By Application
  • 8.5.3 By Test Location
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Technology
  • 8.6.2 By Application
  • 8.6.3 By Test Location
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche
  • 10.2.2 Abbott
  • 10.2.3 QIAGEN
  • 10.2.4 Danaher Corporation
  • 10.2.5 BioMerieux
  • 10.2.6 OraSure Technologies
  • 10.2.7 Binx Health
  • 10.2.8 QuidelOrtho
  • 10.2.9 Cepheid
  • 10.2.10 Siemens Healthineers
  • 10.2.11 Thermo Fisher Scientific
  • 10.2.12 Bio-Rad Laboratories
  • 10.2.13 Hologic
  • 10.2.14 SEKISUI Diagnostics
  • 10.2.15 Bosch Healthcare Solutions
  • 10.2.16 Trivitron Healthcare
  • 10.2.17 Meridian Bioscience
  • 10.2.18 GenMark Diagnostics
  • 10.2.19 Mesa Biotech
  • 10.2.20 Molbio Diagnostics